4-amino-3-phenylbutyric acid has been researched along with Chemical Dependence in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anand, A; Wainblat, E; Weleff, J | 1 |
| Dambrova, M; Kupats, E; Stelfa, G; Vavers, E; Vrublevska, J; Zvejniece, B; Zvejniece, L | 1 |
| Leo, RJ; Mash, JE | 1 |
| Doyno, CR; White, CM | 1 |
| Friend, SF; Jimenez, B; Joshi, YB; Steiger, LR | 1 |
| Hardman, MI; Sprung, J; Weingarten, TN | 1 |
| Jouney, EA | 1 |
| Cantrell, FL; Hwang, JQ; O'Connell, CW; Schneir, AB | 1 |
| Archer, JR; Dargan, PI; Owen, DR; Wood, DM | 1 |
| Balchand, K; Paton-Gay, CL; Rehm, J; Samokhvalov, AV | 1 |
3 review(s) available for 4-amino-3-phenylbutyric acid and Chemical Dependence
| Article | Year |
|---|---|
Safety and Tolerability of the Anxiolytic and Nootropic Drug Phenibut: A Systematic Review of Clinical Trials and Case Reports.
Topics: Anti-Anxiety Agents; gamma-Aminobutyric Acid; Humans; Nootropic Agents; Substance-Related Disorders | 2020 |
Acute phenibut withdrawal: A comprehensive literature review and illustrative case report.
Topics: Akathisia, Drug-Induced; Baclofen; Cyproheptadine; Dexmedetomidine; Diphenhydramine; GABA-A Receptor Antagonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Haloperidol; Humans; Lorazepam; Male; Melatonin; Neuroleptic Malignant Syndrome; Olanzapine; Receptors, GABA; Substance Withdrawal Syndrome; Substance-Related Disorders; Young Adult | 2019 |
Phenibut (β-Phenyl-γ-Aminobutyric Acid): an Easily Obtainable "Dietary Supplement" With Propensities for Physical Dependence and Addiction.
Topics: Behavior, Addictive; Dietary Supplements; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Nootropic Agents; Substance-Related Disorders | 2019 |
7 other study(ies) available for 4-amino-3-phenylbutyric acid and Chemical Dependence
| Article | Year |
|---|---|
Management of Phenibut Use Disorder and Withdrawal in a Geriatric Patient.
Topics: Aged; Benzodiazepines; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Male; Substance-Related Disorders | 2023 |
Phenibut: A Novel Nootropic With Abuse Potential.
Topics: Adult; gamma-Aminobutyric Acid; Humans; Male; Nootropic Agents; Substance Withdrawal Syndrome; Substance-Related Disorders | 2020 |
Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank.
Topics: Drug Overdose; Flunitrazepam; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Oligopeptides; Receptors, GABA; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome; Substance-Related Disorders | 2021 |
Dissociative Intoxication and Prolonged Withdrawal Associated With Phenibut: A Case Report.
Topics: Adult; Baclofen; Delirium; GABA Agonists; gamma-Aminobutyric Acid; Humans; Male; Substance Withdrawal Syndrome; Substance-Related Disorders | 2017 |
Phenibut, the appearance of another potentially dangerous product in the United States.
Topics: Adult; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Male; Substance-Related Disorders; United States | 2014 |
Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity.
Topics: Adult; Female; GABA Agonists; gamma-Aminobutyric Acid; Humans; Illicit Drugs; Male; Middle Aged; Prevalence; Substance-Related Disorders; Young Adult | 2016 |
Phenibut dependence.
Topics: Adult; Baclofen; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Male; Russia; Substance-Related Disorders | 2013 |